Navigation Links
Questcor Reports Fourth Quarter and Full Year 2012 Results
Date:2/26/2013

nd Investor Communications The company will host a conference call and slide presentation via webcast today, February 26, 2013, at 4:30 p.m. ET/ 1:30 p.m. PT. The call can be accessed three ways:

  • By webcast: At Questcor's investor relations website, http://ir.questcor.com/.
  • By telephone: For both "listen-only" participants and those participants who wish to take part in the question-and-answer portion of the call, the telephone dial-in number in the U.S. is (877) 354-0215. For participants outside the U.S., the dial-in number is (253) 237-1173.
  • By audio replay: A replay of the conference call will be available for seven business days following conclusion of the live call. The dial-in number for U.S. participants is (855) 859-2056. For participants outside the U.S., the replay dial-in number is (404) 537-3406. The replay access code for all callers is 95427085.
  • About QuestcorQuestcor Pharmaceuticals, Inc. is a biopharmaceutical company focused on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. Questcor's primary product is H.P. Acthar® Gel (repository corticotropin injection), an injectable drug that is approved by the FDA for the treatment of 19 indications. Of these 19 indications, Questcor currently generates substantially all of its net sales from the following on-label indications: the treatment of proteinuria in the nephrotic syndrome of the idiopathic type, or NS, the treatment of acute exacerbations of multiple sclerosis, or MS, in adults, the treatment of infantile spasms, or IS, in infants and children under two years of age, and the treatment of certain rheumatology related conditions, including the treatment of the rare and closely related neuromuscular disorders dermatomyositis and polymyositis. With respect to nephrotic syndrome, the FDA has approved Acthar to "induce a diuresis or a remission of prote
    '/>"/>

    SOURCE Questcor Pharmaceuticals, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

    Related medicine technology :

    1. Questcor to Report Fourth Quarter and Full Year 2012 Financial Results on February 26, 2013
    2. Questcor Pharmaceuticals Appoints Michael Aldridge to the Position of Senior Vice President, Corporate Strategic Development
    3. Questcor Pharmaceuticals Accelerates Cash Dividend; Payment Date Set for December 21, 2012
    4. Harwood Feffer LLP Announces Investigation of Questcor Pharmaceuticals, Inc.
    5. Questcor to Conduct Conference Call to Discuss Reimbursement Process
    6. Questcor Comments on Insurance Policy Bulletin
    7. Questcor and The Myositis Association Team Up To Support Research and Educational Initiatives in Polymyositis and Dermatomyositis
    8. Questcor Pharmaceuticals to Present at Investor Conferences in September
    9. Questcor Reports Second Quarter Financial Results
    10. Questcor to Report Second Quarter Results on July 24, 2012
    11. Questcor Pharmaceuticals to Present at JMP Securities Healthcare Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/29/2014)... -- Pixcelldata, the innovative Irish developer of ... major new deal with Dutch based eX-Path, global providers ... Marius Nap . The announcement was ... Pathology which is taking placing between August 30th and ... where Pixcelldata will demonstrate its innovative solution. ...
    (Date:8/29/2014)... ANDOVER, Mass. , Aug. ...  (NYSE: PHG ... at the  European Society of ... company is highlighting the full range of its cardiology solutions ... the care continuum from prevention and ...
    (Date:8/28/2014)... Aug. 28, 2014 Reportlinker.com ... report is available in its catalogue: ... Compliance Services Industry (U.S.): Analytics, Extensive ... to 2021, NAIC 541380 ... Testing Laboratories, Safety and Compliance ...
    Breaking Medicine Technology:Pixcelldata Announces New Deal with Dutch Tele-Pathology Specialists eX-Path Ahead of ECP 2014 2Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 2Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 3Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 4Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 5Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 2Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 3Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 4Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 5Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 6
    ... Conn., Aug. 23 MedClean Technologies, Inc. (OTC Bulletin Board: ... technology for the treatment and disposal of ... media, today announced financial results for the 2010 second quarter ... of the recent highlights include : ...
    ... Reaffirms its 2010 Guidance -- XI,AN, China, Aug. 23 /PRNewswire-Asia-FirstCall/ -- ... ... ... = ,; var first_result; // Results are keyed by longUrl, so we need to grab the ...
    Cached Medicine Technology:MedClean Technologies Announces Second Quarter Results 2MedClean Technologies Announces Second Quarter Results 3MedClean Technologies Announces Second Quarter Results 4MedClean Technologies Announces Second Quarter Results 5Huifeng Bio-Pharmaceutical Reported Second Quarter 2010 Financial Results and Reaffirms its 2010 Guidance 2Huifeng Bio-Pharmaceutical Reported Second Quarter 2010 Financial Results and Reaffirms its 2010 Guidance 3Huifeng Bio-Pharmaceutical Reported Second Quarter 2010 Financial Results and Reaffirms its 2010 Guidance 4Huifeng Bio-Pharmaceutical Reported Second Quarter 2010 Financial Results and Reaffirms its 2010 Guidance 5Huifeng Bio-Pharmaceutical Reported Second Quarter 2010 Financial Results and Reaffirms its 2010 Guidance 6Huifeng Bio-Pharmaceutical Reported Second Quarter 2010 Financial Results and Reaffirms its 2010 Guidance 7Huifeng Bio-Pharmaceutical Reported Second Quarter 2010 Financial Results and Reaffirms its 2010 Guidance 8Huifeng Bio-Pharmaceutical Reported Second Quarter 2010 Financial Results and Reaffirms its 2010 Guidance 9
    (Date:8/29/2014)... Honey Gifts, premium Vancouver adult toys ... be selling purse-sized adult toys and erotic products. These ... can be carried in a woman’s purse with complete ... at Honey Gifts is also leak-free and will not ... batteries are common characteristics of Honey Gifts’ portable toys ...
    (Date:8/29/2014)... Ore. (PRWEB) August 29, 2014 University ... of health sciences professionals, announced that Daniel Redwood, DC, ... was named “Educator of the Year,” by the Missouri ... banquet on August 21. , Patrick Montgomery, DC, president ... appointed member of the Missouri House Task Force for ...
    (Date:8/29/2014)... August 29, 2014 The ... revenue growth over the five years to 2014 ... consumers had less disposable income and, consequently, reduced ... visited restaurants less frequently. As a result, demand ... hindering revenue growth. “After 2010, levels of household ...
    (Date:8/29/2014)... Aug. 29, 2014 (HealthDay News) -- The West African Ebola ... Health Organization announcing an estimated 500 new cases this week ... of the new cases arose in Liberia, the U.N. health ... rose sharply, the Associated Press reported. "There ... control," according to the WHO report. "The situation is worsening ...
    (Date:8/29/2014)... CA (PRWEB) August 29, 2014 Evolutions ... Santa Barbara in the Santa Barbara News-Press Readers’ Choice ... won the Readers’ Choice poll as Best Medical Spa. ... 2014 reads the following about Evolutions Medical Spa recognition: ... but it is recognized as a top-notch, cutting-edge medical ...
    Breaking Medicine News(10 mins):Health News:Honey Gifts Now Provides Purse Sized Adult Toys in Vancouver 2Health News:University of Western States Director of Human Nutrition and Functional Medicine Daniel Redwood, DC, named Missouri Educator of the Year by MSCA 2Health News:Fruit and Vegetable Wholesaling in Canada Industry Market Research Report Now Available from IBISWorld 2Health News:Fruit and Vegetable Wholesaling in Canada Industry Market Research Report Now Available from IBISWorld 3Health News:Biggest Ever Weekly Rise in Ebola Cases, U.N. Agency Says 2Health News:Biggest Ever Weekly Rise in Ebola Cases, U.N. Agency Says 3Health News:Evolutions Named Best Medical Spa in Santa Barbara by Santa Barbara News Press 2Health News:Evolutions Named Best Medical Spa in Santa Barbara by Santa Barbara News Press 3
    ... March 22 (HealthDay News) -- New research suggests that middle-age ... less likely to suffer from heart disease over their lives. ... high-fiber diets to lower rates of high blood pressure, obesity ... to the conclusion after studying the results of a 2003-2008 ...
    ... to be female, suffer from a neurological or mental disorder, ... in the March issue of the Journal of the ... alcohol abuse by the perpetrator plays a substantial role and ... professor of environmental and occupational health sciences at the University ...
    ... To help continue its internationally recognized work in Lewy ... awarded Mayo Clinic a $1 million gift, pledged over four ... Alzheimer,s and Parkinson,s diseases , is the second ... VIDEO ALERT: Additional audio and video resources, including ...
    ... 22 (HealthDay News) -- A low-cost screening test detected potentially ... children and teens in a pilot study. The findings ... for heart conditions that can lead to sudden cardiac arrest ... said in a hospital news release. Researchers found that ...
    ... (March 22, 2011) When physical therapy and drugs fail to ... fusion surgery as a last resort, but two new studies ... involved, artificial disc replacement may give better long-term results at ... 49 percent lower, and four years out from surgery, artificial ...
    ... Salamon HealthDay Reporter , MONDAY, March 21 ... presumably have more opportunities for tanning -- are nearly ... cancer melanoma as their poorest counterparts, a new study ... incidence, ultraviolet (UV) light exposure and socioeconomic status, scientists ...
    Cached Medicine News:Health News:Elderly victims of abuse often use alcohol or drugs, study says 2Health News:Gift will allow Mayo researchers to explore cause of dementia in the elderly 2Health News:Gift will allow Mayo researchers to explore cause of dementia in the elderly 3Health News:Screening Seems to Catch Dangerous Heart Condition in Kids 2Health News:For back, neck pain, artificial disc replacement has cost, outcome advantages over fusion surgery 2Health News:For back, neck pain, artificial disc replacement has cost, outcome advantages over fusion surgery 3Health News:Richer White Women More Prone to Melanoma, Study Finds 2Health News:Richer White Women More Prone to Melanoma, Study Finds 3
    Designed to minimize emblolic debris in SVGs and carotids...
    ... therapy extends the ability of interventional ... coronary artery disease, and provides non-interventional ... in the treatment of patients who ... EECP therapy provides a noninvasive, atraumatic ...
    ... The dual lumen petite titanium ... mm catheter (each lumen) and ... oval lumen catheters offer larger ... catheter strength. Dual lumen offset-tip ...
    ... The dual lumen M.R.I. model ... 1.2 mm inner diameter catheters ... catheters offer larger lumen equivalency ... ,Dual lumen offset-tip catheters are ...
    Medicine Products: